Iowa to Pause Administering Johnson & Johnson COVID-19 Vaccine

DES MOINES, Iowa – With the announcement from the Centers for Disease Control (CDC) and Food and Drug Administration (FDA) on Tuesday morning, the Iowa Department of Public Health (IDPH) has advised that all Iowa vaccine providers pause administration of the Johnson & Johnson COVID-19 vaccine until more details are confirmed.

The CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the Johnson & Johnson vaccine. All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination. Right now, these adverse events appear to be extremely rare.